Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
Filter
  • RISK-FACTORS  (3)
  • ACTINIC KERATOSES  (2)
Keywords
  • 1
    Keywords: CANCER ; tumor ; BLOOD ; carcinoma ; CELL ; human ; DIAGNOSIS ; COHORT ; EPIDEMIOLOGY ; RISK ; TIME ; INFECTION ; ANTIGEN ; antibodies ; antibody ; virus ; NO ; DIFFERENCE ; PLASMA ; COMPONENT ; VIRUS-LIKE PARTICLES ; HPV ; case-control studies ; squamous cell carcinoma ; INDIVIDUALS ; L1 ; INFECTIONS ; PREVALENCE ; European Prospective Investigation into Cancer and Nutrition ; nutrition ; SKIN-CANCER ; glutathione-S-transferase ; CELL CARCINOMA ; ONCOLOGY ; case control study ; case-control study ; PATTERN ; EPIDERMODYSPLASIA-VERRUCIFORMIS ; prospective studies ; case control studies ; ACTINIC KERATOSES ; USA ; prospective ; prospective study ; UNIT ; SQUAMOUS-CELL ; serology ; HUMAN PAPILLOMAVIRUSES ; SEROPREVALENCE ; case control ; cutaneous squamous cell carcinoma (SCC) ; HPV types ; human papillomavirus (HPV) ; ORGAN-TRANSPLANTATION ; prospective case-control
    Abstract: In a prospective pilot study nested in the EPIC-Oxford cohort, we examined the seroprevalence of antibodies against the L1 antigen of 38 human papilloma virus (HPV) types among 39 cases of cutaneous squamous cell carcinoma (SCC) for whom plasma was collected prior to diagnosis (incident) and 80 controls. Fifteen cases having already developed SCC at blood collection (prevalent) were also tested. There were no statistically significant differences in the seroprevalence of antibodies against any of the HPV types examined between incident cases and controls, nor was there a difference in the seroprevalence of multiple infections. However, consistent with results from published case-control studies, the seroprevalence of many beta-HPV types was higher among prevalent cases than among either incident cases or controls. For example the seroprevalence of antibodies against HPV-8 was 20% (16/80) in controls, 23% (9/39) among incident cases and 40% (6115) among prevalent cases. Among the incident cases only, the seroprevalence was 16% (5/32) among those for whom blood was collected 18+ months prior to diagnosis, but 57% (4/7) among those for whom diagnosis was within 18 months of blood collection, a pattern seen for many of the HPV types. This might suggest that if HPV is involved in the aetiology of SCC, the process occurs close to the time of diagnosis, or that the antibody response observed in people with SCC is a consequence of tumor formation. Further and larger prospective studies are needed to clarify the role of HPV in the aetiology of cutaneous SCC. (C) 2007 Wiley-Liss, Inc
    Type of Publication: Journal article published
    PubMed ID: 17565742
    Signatur Availability
    BibTip Others were also interested in ...
  • 2
    Keywords: CANCER ; carcinoma ; CELL ; human ; COMMON ; COHORT ; EPIDEMIOLOGY ; HISTORY ; POPULATION ; RISK ; PROTEINS ; TIME ; DNA ; INFECTION ; RISK-FACTORS ; ANTIGEN ; SKIN ; papillomavirus ; ASSOCIATION ; SUSCEPTIBILITY ; antibodies ; antibody ; AGE ; WOMEN ; MEN ; RISK FACTOR ; human papillomavirus ; VIRUS-LIKE PARTICLES ; HPV ; HUMAN-PAPILLOMAVIRUS ; POPULATIONS ; case-control studies ; squamous cell carcinoma ; L1 ; PREVALENCE ; glutathione-S-transferase ; SERUM ; CELL CARCINOMA ; case control study ; case-control study ; RECIPIENTS ; HPV 16 ; TECHNOLOGY ; ACTINIC KERATOSES ; NONMELANOMA SKIN-CANCER ; HISTOLOGY ; USA ; UNIT ; RISK-FACTOR ; SQUAMOUS-CELL ; IMMUNOCOMPETENT INDIVIDUALS ; serology ; SEROPREVALENCE ; cutaneous squamous cell carcinoma (SCC) ; HPV types ; human papillomavirus (HPV) ; Genital warts ; CONFIDENCE ; organ transplant recipients ; SCC
    Abstract: A case-control study was conducted in 140 people with histology proven cutaneous squamous cell carcinoma (SCC) and 454 controls, nested within 2 cohorts of organ transplant recipients (OTR) recruited in London and Oxford between 2002 and 2006. All participants had a skin examination, completed a questionnaire and had serum tested for antibodies against the L1 antigen of 34 HPV types using Luminex technology. SCC was more common in men than women (odds ratio [OR] = 1.7, 95% confidence interval [CI]: 1.1-2.8, p = 0.02) and in people with susceptibility to burn easily (OR = 3.0, 95%CI: 1.9-4.8; p 〈 0.001). The risk increased with increasing age (p-trend 〈 0.001), increasing time since transplant (p-trend 〈 0.001), increasing self-reported number of sunburns as a child (p(trend) 〈 0.001) and with the presence of viral warts (p 〈 0.001). As expected, antibodies against HPV 16 were associated with a self-reported history of an abnormal cervical smear among women (OR 5.1, 95%CI: 2.6-10.2) and antibodies against HPV 6 were associated with a self-reported history of genital warts (OR 4.0, 95%CI: 2.2-7.2). However, no clear associations between any of the HPV types examined (including cutaneous betaHPVs) and SCC were identified. For example, the seroprevalence of HPV 5 was 15% among cases and 9% among controls (p = 0.09) and the seroprevalence of HPV 8 was 23% among cases and 21% among controls (p = 0.6). Nor was seropositivity to multiple types associated with SCC. These serological data do not provide evidence for a role for HPV in the aetiology of cutaneous SCC among OTR in two UK-based populations. (C) 2009 UICC
    Type of Publication: Journal article published
    PubMed ID: 19588489
    Signatur Availability
    BibTip Others were also interested in ...
  • 3
    Keywords: CANCER ; POPULATION ; RISK ; INFECTION ; RISK-FACTORS ; SKIN ; ASSOCIATION ; antibody ; MALIGNANCIES ; AGE ; risk factors ; skin cancer ; RISK FACTOR ; HUMAN-PAPILLOMAVIRUS DNA ; SQUAMOUS-CELL CARCINOMA ; PREVALENCE ; human papilloma virus ; SUNLIGHT ; glutathione-S-transferase ; HPV INFECTION ; IMMUNOCOMPETENT INDIVIDUALS ; GROWTH-FACTOR RECEPTORS ; KERATOSES ; renal transplant recipients ; seborrhoeic warts
    Abstract: Background Renal transplant recipients (RTR) have a well recognized increased risk of cutaneous malignancy. A clinical observation that RTR with skin cancer often had multiple seborrhoeic warts prompted an investigation in RTR into the relationship between seborrhoeic warts and skin cancer and an exploration into potential risk factors for seborrhoeic warts in this population, including infection with human papillomavirus (HPV). Methods This was a case control study involving 308 RTR. Clinical examinations identified seborrhoeic warts. Histological records reviewed to look for evidence of prior cutaneous malignancy. Seroprevalence of antibodies to 34 different HPV types tested using multiplex serology. Odds ratios (OR) calculated using unconditional logistic regression analysis to look for associations between skin cancer, HPV infection and seborrhoeic warts, controlling for potential confounding factors of gender, age and time since transplantation. Results Seborrhoeic warts were associated with non-melanoma skin cancer [OR = 3.7; 95% confidence intervals (CI) ranging from 1.6-8.9; P = 0.002] when confounding factors of gender, age and time since transplantation were controlled for. There was also an association between seborrhoeic warts and viral warts (OR = 3.0, CI: 1.6-5.4; P 〈 0.0001), but no association between seborrhoeic warts and infection with single or multiple HPV types. Conclusions Seborrhoeic warts are associated with cutaneous malignancy, but not with any of the HPV types tested. The reasons for this association are unclear. RTR with multiple seborrhoeic warts may require more regular cutaneous examination to monitor for early signs of skin cancer
    Type of Publication: Journal article published
    Signatur Availability
    BibTip Others were also interested in ...
  • 4
    Keywords: DISEASE ; RISK-FACTORS ; LYMPHOMA ; WOMEN ; UNITED-STATES ; IMMUNE-RESPONSE ; REPRODUCTIVE FACTORS ; PREGNANCY ; parity ; B-CELL ; NON-HODGKIN-LYMPHOMA ; non-Hodgkin ; HORMONAL FACTORS ; CHILDBEARING ; Contraception ; EXOGENOUS HORMONE USE ; Hodgkin
    Abstract: BACKGROUND: The study of lymphomagenesis has rarely focused on hormonal factors. Higher incidence rates are observed for many lymphoma subtypes in men compared with women suggesting an underlying association. Our goal was to investigate the association between reproductive factors and lymphomas. METHODS: The Epilymph study is a multicenter case-control study carried out in six European countries from 1998 to 2004. Female cases of mature T-cell neoplasms (n = 52), Hodgkin lymphoma (n = 147), and mature B-cell neoplasms (n = 795), including its common subtypes, and their respective controls (n = 1,141) frequency matched by age, gender, and center were considered. RESULTS: An odds reduction of 29% (95% CI -46 to -6%) was observed for mature T-cell neoplasms for each child increase among parous women and of 13% (95% CI -19 to -7%) for mature B-cell neoplasms; while no association was observed for Hodgkin lymphoma. By B-cell neoplasm subtypes, these associations were found for chronic lymphocytic leukemia/small lymphocytic lymphoma (-21%, 95% CI -31 to -9%) and diffuse large B-cell lymphoma (DLBCL; -14%; 95% CI -23 to -3%). Overall, no associations were observed with age at first and last pregnancy, and ever use of hormonal contraceptives and lymphoma. Higher odds ratios for a short-term use of hormonal contraceptives (〈5 years), but not for a long-term use, were observed for mature B-cell neoplasms, DLBCL, and follicular lymphoma compared with never use. CONCLUSION: These data support the hypothesis that increased parity confers a protective effect against lymphoma. Less clearly, our results also indicate that hormonal contraceptives could play a role.
    Type of Publication: Journal article published
    PubMed ID: 22116538
    Signatur Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...